These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3690477)

  • 21. A prescription for better prescriptions.
    Woosley RL
    Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
    [No Abstract]   [Full Text] [Related]  

  • 22. Canadian marketing codes: how well are they controlling pharmaceutical promotion?
    Lexchin J
    Int J Health Serv; 1994; 24(1):91-104. PubMed ID: 8150569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Considerations in the relationship between the American College of Chest Physicians and industry.
    Lever A
    Chest; 2001 Apr; 119(4):1257-9. PubMed ID: 11296196
    [No Abstract]   [Full Text] [Related]  

  • 24. Information or advertising?
    Coulter A
    Health Expect; 2001 Dec; 4(4):203-4. PubMed ID: 11703492
    [No Abstract]   [Full Text] [Related]  

  • 25. The Canadian Medical Association Code of Ethics annotated for psychiatrists. The position of the Canadian Psychiatric Association.
    Mellor C
    Can J Psychiatry; 1980 Aug; 25(5):432-8. PubMed ID: 7407750
    [No Abstract]   [Full Text] [Related]  

  • 26. Two cheers for the CMA's new guidelines on drug company-MD relations The CMA's MD-drug industry guidelines offer advice, nothing more.
    Rapp MS; Woollard R
    CMAJ; 1991 Dec; 145(11):1497-9. PubMed ID: 11649303
    [No Abstract]   [Full Text] [Related]  

  • 27. Doctors, medical societies and the pharmaceutical industry.
    Mayers I
    Can Respir J; 2002; 9(5):297-8, 301-2. PubMed ID: 12410321
    [No Abstract]   [Full Text] [Related]  

  • 28. Psychiatric training program engagement with the pharmaceutical industry: an educational issue, not strictly an ethical one.
    Mohl PC
    Acad Psychiatry; 2005; 29(2):215-21. PubMed ID: 15937270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research training and productivity among faculty: the Canadian Association of Professors of Psychiatry and the Canadian Psychiatric Association Survey.
    el-Guebaly N; Atkinson M
    Can J Psychiatry; 1996 Apr; 41(3):144-9. PubMed ID: 8722642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship Between the American Academy of Pediatrics and Infant Formula Companies.
    Sharfstein JM; Silver DL
    JAMA Pediatr; 2017 Jul; 171(7):613-614. PubMed ID: 28464121
    [No Abstract]   [Full Text] [Related]  

  • 31. Medical professionalism--focusing on the real issues.
    Ruane TJ
    N Engl J Med; 2000 Sep; 343(10):739-40. PubMed ID: 10979775
    [No Abstract]   [Full Text] [Related]  

  • 32. Marketing Rx&D: one step forward, two steps back.
    Yeo M
    CMAJ; 2003 May; 168(10):1273-4; discussion 1274-5. PubMed ID: 12743072
    [No Abstract]   [Full Text] [Related]  

  • 33. Physicians and the pharmaceutical industry (update 1994). Canadian Medical Association.
    CMAJ; 1994 Jan; 150(2):256A-256F. PubMed ID: 8287348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partnerships between academic psychiatry and the pharmaceutical industry: the Lilly MAP Initiative.
    Singh B; Copolov D; Grainger D; Goh J
    Australas Psychiatry; 2004 Sep; 12(3):220-4; discussion 225-6. PubMed ID: 15715778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Just saying "no" to pharmaceutical sponsorship.
    Menkes DB; Maharajh M
    N Z Med J; 2007 Mar; 120(1251):U2471. PubMed ID: 17384699
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ethical advice regarding the relationship between psychiatrists and the pharmaceutical industry].
    Morrens M; De Fruyt J; Pattyn T; Surmont M; Pieters G
    Tijdschr Psychiatr; 2015; 57(4):268-73. PubMed ID: 25904431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Big pharma' and psychiatry: 'the devil is in the dyad'.
    Anand S
    Aust N Z J Psychiatry; 2012 Dec; 46(12):1118-9. PubMed ID: 23212138
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceutical company promotion: striking a balance.
    Day R
    Aust N Z J Med; 1998 Jun; 28(3):291-3. PubMed ID: 9673738
    [No Abstract]   [Full Text] [Related]  

  • 39. Commentary by an academic child psychiatrist on the relationship of the pharmaceutical industry, academia, psychiatric practice, and the Food and Drug Administration.
    Varley CK
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):292-4. PubMed ID: 17630861
    [No Abstract]   [Full Text] [Related]  

  • 40. New guidelines examine drug firm, CME relations.
    Randall T
    JAMA; 1991 Mar; 265(11):1354. PubMed ID: 1842200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.